De Maria R - Search Results

1

Ceramide inhibits antigen uptake and presentation by dendritic cells.

Sallusto F, Nicolò C, De Maria R, Corinti S, Testi R. Sallusto F, et al. Among authors: de maria r. J Exp Med. 1996 Dec 1;184(6):2411-6. doi: 10.1084/jem.184.6.2411. J Exp Med. 1996. PMID: 8976196 Free PMC article.

2

Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase.

Cifone MG, De Maria R, Roncaioli P, Rippo MR, Azuma M, Lanier LL, Santoni A, Testi R. Cifone MG, et al. Among authors: de maria r. J Exp Med. 1994 Oct 1;180(4):1547-52. doi: 10.1084/jem.180.4.1547. J Exp Med. 1994. PMID: 7523573 Free PMC article.

3

The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells.

Testi R, D'Ambrosio D, De Maria R, Santoni A. Testi R, et al. Among authors: de maria r. Immunol Today. 1994 Oct;15(10):479-83. doi: 10.1016/0167-5699(94)90193-7. Immunol Today. 1994. PMID: 7945773 Review.

4

Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors.

De Maria R, Cifone MG, Trotta R, Rippo MR, Festuccia C, Santoni A, Testi R. De Maria R, et al. J Exp Med. 1994 Nov 1;180(5):1999-2004. doi: 10.1084/jem.180.5.1999. J Exp Med. 1994. PMID: 7964477 Free PMC article.

5

Continuous in vivo activation and transient hyporesponsiveness to TcR/CD3 triggering of human gut lamina propria lymphocytes.

De Maria R, Fais S, Silvestri M, Frati L, Pallone F, Santoni A, Testi R. De Maria R, et al. Eur J Immunol. 1993 Dec;23(12):3104-8. doi: 10.1002/eji.1830231209. Eur J Immunol. 1993. PMID: 8258323

6

Persistent in vivo activation and transient anergy to TCR/CD3 stimulation of normal human intestinal lymphocytes.

DeMaria R, Fais S, Testi R. DeMaria R, et al. Adv Exp Med Biol. 1995;371A:43-6. doi: 10.1007/978-1-4615-1941-6_8. Adv Exp Med Biol. 1995. PMID: 8525960 No abstract available.

7

Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation.

De Maria R, Boirivant M, Cifone MG, Roncaioli P, Hahne M, Tschopp J, Pallone F, Santoni A, Testi R. De Maria R, et al. J Clin Invest. 1996 Jan 15;97(2):316-22. doi: 10.1172/JCI118418. J Clin Invest. 1996. PMID: 8567950 Free PMC article.

8

Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.

Cascino I, Papoff G, De Maria R, Testi R, Ruberti G. Cascino I, et al. Among authors: de maria r. J Immunol. 1996 Jan 1;156(1):13-7. J Immunol. 1996. PMID: 8598453

9

Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM.

Giordano C, De Maria R, Stassi G, Todaro M, Richiusa P, Giordano M, Testi R, Galluzzo A. Giordano C, et al. Among authors: de maria r. Diabetologia. 1995 Dec;38(12):1449-54. doi: 10.1007/BF00400606. Diabetologia. 1995. PMID: 8786019

10

Multiple pathways originate at the Fas/APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal.

Cifone MG, Roncaioli P, De Maria R, Camarda G, Santoni A, Ruberti G, Testi R. Cifone MG, et al. Among authors: de maria r. EMBO J. 1995 Dec 1;14(23):5859-68. doi: 10.1002/j.1460-2075.1995.tb00274.x. EMBO J. 1995. PMID: 8846779 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

558 results

Search Page

Filters